Lombard Odier Asset Management (Switzerland)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Lombard Odier Asset Management (Switzerland)’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,243	Closed	-$1.16M	–	150
2020 Q3	$1.16M	Buy	+2,243	New	+$1.14M	0.12%	126
2020 Q2	–	Sell	-1,071	Closed	-$375K	–	171
2020 Q1	$375K	Buy	+1,071	New	+$394K	0.05%	233
2017 Q1	–	Sell	-17,500	Closed	-$3.19M	–	358
2016 Q4	$3.19M	Buy	17,500 +5,000	+40%	+$852K	0.81%	36
2016 Q3	$2.05M	Buy	+12,500	New	+$1.9M	0.49%	39
2015 Q1	–	Sell	-23,312	Closed	-$2.83M	–	398
2014 Q4	$2.83M	Buy	23,312 +1,053	+5%	+$121K	0.3%	67
2014 Q3	$2.54M	Buy	+22,259	New	+$2.64M	0.07%	310

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lombard Odier Asset Management (Switzerland)'s BIO Position: Q4 2020 in Review

Lombard Odier Asset Management (Switzerland) sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2020, closing a stake of 2,243 shares — an estimated $1.16M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in BIO in Q3 2014 and held it in 6 quarters. The position peaked at $3.19M in Q4 2016. 491 funds tracked by Wall St. Rank hold BIO as of Q4 2020.

Lombard Odier Asset Management (Switzerland) reported no remaining Bio-Rad Laboratories Class A position as of Q4 2020 after selling out during the quarter.
Lombard Odier Asset Management (Switzerland) sold 2,243 Bio-Rad Laboratories Class A shares in Q4 2020, an estimated $1.16M.
Lombard Odier Asset Management (Switzerland) first reported a position in Bio-Rad Laboratories Class A in Q3 2014 and held it in 6 quarters.
Lombard Odier Asset Management (Switzerland)'s Bio-Rad Laboratories Class A position peaked at $3.19M in Q4 2016.
491 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2020.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2020, filed 16 Feb 2021.